| |
|
EMFCSC PRESIDENT AND DIRECTOR OF THE CENTRE
Antonino Zichichi
DIRECTOR OF THE SCHOOL
Michele Pavone-Macaluso
DIRECTORS OF THE COURSE
Giuseppe Martorana - Bologna, Italy
Gigliola Sica – Roma, Italy
SCIENTIFIC SECRETARIAT
Alessandro Bertaccini – Bologna, Italy
Giario Conti – Como, Italy
Fortunata Iacopino – Roma, Italy
Carlo Pavone – Palermo, Italy
e-mail: slacavera@libero.it
ORGANISING SECRETARIAT
E.DI.PO. s.r.l. – Serenella La Cavera
Via Libertà 103, 90143 Palermo
Tel. ++39091343120 / ++39091340255 Fax ++39091340440
e-mail: edi.po@tiscali.it / info@edipocongressi.com
http://www.edipocongressi.com
The Course will be held under the auspices of:
• Italian Society for Urological Oncology (SIUrO)
• European Organisation for Research and Treatment of Cancer (EORTC) – GU Group
• University of Palermo
• University of Bologna
• Faculty of Medicine of the Catholic University of the Sacred Heart of Rome
• Italian Ministry of Health
• Italian Ministry of Education, University and Scientific Research
• Sicilian Regional Government
• World Federation of Scientists.
LECTURERS AND CHAIRMEN
• Giorgio Arcangeli, Roma – Italy
• Cecilia Balbi, Genova – Italy
• Carlo Barone, Roma – Italy
• Michele Battaglia, Bari – Italy
• Alessandro Bertaccini, Bologna – Italy
• Francesco Boccardo, Genova – Italy
• Enrico Bollito, Orbassano (TO) – Italy
• Aldo Vittorio Bono, Varese – Italy
• Sergio Bracarda, Perugia – Italy
• Maurizio Brausi, Carpi (MO) – Italy
• Roberto Cauda, Roma – Italy
• Giario Conti, Como – Italy
• Douglas M. Dahl, Boston – USA
• Theo M. de Reijke, Amsterdam – The Netherlands
• Francesco Ferraù, Taormina (ME) – Italy
• Vincenzo Ficarra, Verona – Italy
• Ziya Kirkali, Izmir – Turkey
• Alberto Lapini, Firenze – Italy
• Raffaele Lodi, Bologna – Italy
• Giuseppe Martorana, Bologna – Italy
• Robert P. Millar, Edinburgh – United Kingdom
• Rodolfo Montironi, Ancona – Italy
• Donald W.W. Newling, Macclesfield – United Kingdom
• Carlo Patriarca, Melegnano (MI) – Italy
• Carlo Patrono, Roma – Italy
• Michele Pavone-Macaluso, Palermo – Italy
• Tommaso Prayer Galetti, Padova – Italy
• Domenico Ribatti, Bari – Italy
• Licia Rivoltini, Milano – Italy
• Matteo Antonio Russo, Roma – Italy
• Vincenzo Scattoni, Milano – Italy
• William U. Shipley, Boston – USA
• Gigliola Sica, Roma – Italy
• Salvatore Siracusano, Trieste – Italy
• Raffaele Tenaglia, Chieti – Italy
• Riccardo Valdagni, Milano – Italy
• Sergio Villa, Milano – Italy
• Marina Ziche, Siena – Italy
PROGRAMME
Thursday, 20 April 2006
Arrival
Welcome party
SCIENTIFIC SESSIONS
Friday, 21 April 2006
OPENING OF THE COURSE
08:30-08:45
G. Martorana, G. Sica
BASIC RESEARCH
Chair: M. Pavone-Macaluso, G. Sica
08:45-09:10
R.P. Millar: GnRH receptors and signal-transduction
mechanisms operating in prostate cancer
09:10- 09:35
G. Sica: Direct effects of GnRH analogues in prostate cancer cells
09:35-10:00
M. Pavone-Macaluso: The impact of GnRH analogues in prostate cancer treatment
CLINICAL SESSION
Chair: G. Conti, R. Tenaglia
10:00-10:20
V. Scattoni: The role of PSA today
10:20-10:40
T. Prayer Galetti:
Recommendations for biopsying
10:40-11:00
C. Patriarca: Prostate cancer mimicks
11:00-11:30 Coffee break
11:30-11:50
R. Montironi: What’s new on Gleason score
11:50-12:10
R. Valdagni: Predictive factors and radiation therapy
12:10-12:30
A. Bertaccini: Positive biopsy. When to treat prostate cancer?
12:30-13:00
A. Bertaccini, D.M. Dahl, R. Lodi: Staging: innovations in the imaging
Lunch time
15:00-19:00
ROLE PLAYING ON DAILY ISSUES
A. Bertaccini, G. Conti, D.M. Dahl, A. Lapini, R. Lodi, R.P. Millar,
R. Montironi,
C. Patriarca, M. Pavone-Macaluso, T. Prayer Galetti,
V. Scattoni, G. Sica, S. Siracusano,
R. Tenaglia, R. Valdagni
15:00-15:30
Group definition and mission assignation to each group
15:30-17:00
Mission elaboration by groups (separately)
17:00-17:30 Coffee break
17:30-19:00
Result presentation by groups – comments by the audience and tutors – take home messages by the tutors (plenary session)
Saturday, 22 April 2006
BASIC RESEARCH
Chair: C. Balbi, M. Ziche
08:45-09:10
D. Ribatti: Mechanisms of tumour angiogenesis
09:10- 09:35
M. Ziche: Role of angiogenesis in prostate cancer
09:35-10:00
S. Bracarda: Antiangiogenic agents in the treatment of tumours of the genitourinary tract
CLINICAL SESSION
Chair: A.V. Bono, M. Brausi
10:00-10:40
D.M. Dahl, W.U. Shipley: Therapy of localized prostate cancer: strategy and results of standard treatments
10:40-11:00
R. Valdagni: Radical radiation and prostate cancer: limits of dose escalation
11:00-11:30 Coffee break
11:30-11:45
G. Conti: Results of alternative treatments for localized prostate cancer
11:45-12:00
E. Bollito: Effects of therapies on histology
12:00-12:15
M. Brausi: Which strategies for locally advanced prostate cancer?
12:15-12:45
G. Arcangeli, F. Boccardo: Adjuvant treatment for locally advanced prostate cancer
12:45-13:00
D.W.W. Newling: The role of adjuvant hormone therapy in the management of early prostate cancer. The results of the third analysis of the EPC trial data
13:00-13:15
V. Ficarra: Treatments and quality of life in locally advanced prostate cancer
Lunch time
15:00-19:00
ROLE PLAYING ON DAILY ISSUES
G. Arcangeli, C. Balbi, F. Boccardo, E. Bollito, A.V. Bono, S. Bracarda,
M. Brausi,G. Conti, D.M. Dahl,
V. Ficarra, D.W.W. Newling,
D. Ribatti,
W.U. Shipley, R. Valdagni,
M. Ziche
15:00-15:30
Mission assignation to each group
15:30-17:00
Mission elaboration by groups (separately)
17:00-17:30 Coffee break
17:30-19:00
Result presentation by groups – comments by the audience and tutors – take home messages by the tutors (plenary session)
Sunday, 23 April 2006
BASIC RESEARCH
Chair: R. Cauda, M.A. Russo
08:45-09:10
M.A. Russo: Prostate cancer and inflammation
09:10- 09:35
C. Patrono: Pharmacology and clinical read-outs of COX-isozyme inhibition
09:35-10:00
C. Barone: The use of cyclooxygenase 2 inhibitors in the prevention and treatment of genitourinary tumours
CLINICAL SESSION
Chair: Z. Kirkali, G. Martorana
10:00-10:30
S. Bracarda, S. Villa: Which therapeutic options in advanced and hormonorefractory prostate cancer
10:30-10:50
Z. Kirkali: New molecules in the treatment of prostate cancer
10:50-11:10
D.W.W. Newling: New therapeutic possibilities for the medical management
of prostate cancer
11:10-11:40 Coffee break
11:40-12:00
T.M. de Reijke: Clinical trials of the EORTC urological group
12:00- 12:20
V. Ficarra: Focus on quality of life in patients with advanced and hormonorefractory prostate cancer
12:20-12:40
G. Conti: Chemoprevention of prostate cancer with finasteride - update of PCPT study
12:40- 13:00
L. Rivoltini: Therapeutic anti-tumour vaccines in prostate cancer
Lunch time
15:00-19:00
ROLE PLAYING ON DAILY ISSUES
C. Barone, M. Battaglia, S. Bracarda, R. Cauda, G. Conti, T.M. de Reijke, F. Ferraù, V. Ficarra, Z. Kirkali, G. Martorana,
D.W.W. Newling,
C. Patrono, L. Rivoltini, M.A. Russo, S. Villa
15:00-15:30
Mission assignation to each group
15:30-17:00
Mission elaboration by groups (separately)
17:00-17:30 Coffee break
17:30-19:00
Result presentation by groups – comments by the audience and tutors – take home messages by the tutors (plenary session)
CLOSURE OF THE COURSE
Monday, 24 April 2006
Departure
|
|
Up... 
